Notably, the CYP17A1 rs743572 polymorphism has been implicated in multiple cancers, spanning organs such as breast, lung, prostate, liver, etc. However, existing findings exhibit inconsistencies, likely stemming from limited sample sizes. This evidence concerns the gene CYP17A1 and cancer.